review published in clinical science re l-carnitine and mitochondria Frontiers The Role of l-Carnitine in

Targeting TXNRD1 maintains efficacy of first-line therapy in vivo SCLC patients typically show high initial response rates to cisplatin-based chemotherapy, followed by relapse shortly after completing first-line therapy

Copper itself is essential for enzymatic processes that protect the skin from oxidative stress

10 After attainment of steady state following 4 days of oral administration of Levocarnitine Oral Solution USP (2000 mg q12h) to 15 healthy male volunteers, the mean urinary excretion of levocarnitine during a single dosing interval (12h) was about 9% of the orally administered dose (uncorrected for endogenous urinary excretion)

10.3390/pharmaceutics13091348 7 BarrettT.WilhiteS